BeStock  
股票 › 医疗器械 › ZBH

捷迈邦美 ZBH

美股市值排名 #930医疗器械
$105.59 −$1.26 (-1.18%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $105.59 0.00%
开盘$103.21
昨收$106.85
当日区间$103.21 – $106.96
成交量2.66M
市值$19.98B
市盈率(TTM)26.7
股息率0.91%

基本面

最新报告季度:Q2, ended Jun 2026

营收$2.18B+4.8% YoY
营业利润$374.00M-5.7% YoY
净利润$199.60M+30.1% YoY
摊薄每股收益$1.03+33.8% YoY
自由现金流$331.40M+11.2% YoY
经营现金流$447.80M

营收,近8个季度

$1.8BSep '24$2.0BDec '24$1.9BMar '25$2.1BJun '25$2.0BSep '25$2.2BDec '25$2.1BMar '26$2.2BJun '26

净利润,近8个季度

$249.2MSep '24$240.1MDec '24$182.6MMar '25$153.4MJun '25$231.2MSep '25$137.9MDec '25$238.3MMar '26$199.6MJun '26

各季度摊薄每股收益

1.23Sep '241.20Dec '240.91Mar '250.77Jun '251.16Sep '250.71Dec '251.22Mar '261.03Jun '26

各季度自由现金流

$328.9MSep '24$421.4MDec '24$335.8MMar '25$298.1MJun '25$353.7MSep '25$432.6MDec '25$284.1MMar '26$331.4MJun '26

年度营收

$6.1BFY20$6.8BFY21$6.9BFY22$7.4BFY23$7.7BFY24$8.2BFY25

盈利能力与资产负债表

毛利率69.9%
营业利润率16.3%
净利率9.5%
净资产收益率6.4%
资产收益率3.5%
投入资本回报率5.3%
流动比率1.69
负债/资产比率44.6%
现金及投资$410.00M
总负债$7.48B
净现金(净负债)-$7.07B
自由现金流/营收16.5%

营收构成

2026/Q2 季度

按业务线

  • Knees$828.90M 38.1%
  • Sports Medicine, Upper Extremities, Foot and Ankle; Trauma, Craniomaxillofacial and Thoracic (S.E.T)$586.00M 26.9%
  • Hips$562.70M 25.8%
  • Technology & Data, Bone Cement and Surgical$199.40M 9.2%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $2.18B $2.09B $8.23B $2.24B $2.00B
营业总收入 $2.18B $2.09B $8.23B $2.24B $2.00B
营业成本 $635.50M $576.20M $2.49B $792.40M $559.30M
毛利润 $1.54B $1.51B $5.74B $1.45B $1.44B
营业费用 $1.17B $1.12B $4.38B $1.17B $1.10B
销售及管理费用 $899.30M $849.90M $3.26B $872.30M $811.40M
研发费用 $104.80M $103.40M $458.50M $118.70M $115.90M
折旧、摊销与折耗 $163.40M $162.10M $665.90M $177.70M $176.50M
-折旧与摊销 $163.40M $162.10M $665.90M $177.70M $176.50M
营业利润 $374.00M $395.10M $1.36B $282.60M $338.30M
非经营性利息净收入(支出) -$72.90M -$68.80M -$292.80M -$71.90M -$75.40M
非经营性利息支出 $72.90M $68.80M $292.80M $71.90M $75.40M
其他收入(支出) -$46.00M -$24.90M -$232.60M -$112.80M $16.30M
特殊收益(费用) -$47.90M -$21.90M -$258.10M -$128.20M $13.00M
-减:重组及并购费用 $47.90M $21.90M $258.10M $128.20M -$13.00M
其他非经营性收入(支出) $1.90M -$3.00M $25.50M $15.40M $3.30M
税前利润 $255.10M $301.30M $830.80M $98.00M $279.20M
税费 $55.50M $63.00M $125.70M -$39.90M $48.00M
净利润 $199.60M $238.30M $705.10M $137.90M $231.20M
持续经营利润 $199.60M $238.30M $705.10M $137.90M $231.20M
少数股东权益 $1.30M $200,000.00 -$100,000.00 -$1.50M $300,000.00
归属母公司净利润 $198.30M $238.10M $705.10M $139.30M $230.90M
归属普通股股东净利润 $198.30M $238.10M $705.10M $139.30M $230.90M
基本每股收益 $1.03 $1.22 $3.56 $0.71 $1.17
摊薄每股收益 $1.03 $1.22 $3.55 $0.71 $1.16
每股股息 $0.24 $0.24 $0.96 $0.24 $0.24

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $22.80B $22.72B $23.09B $23.09B $23.49B
流动资产合计 $5.10B $4.96B $5.12B $5.12B $5.83B
现金及现金等价物与短期投资 $410.00M $424.20M $591.90M $591.90M $1.29B
-现金及现金等价物 $410.00M $424.20M $591.90M $591.90M $1.29B
应收款 $1.77B $1.73B $1.70B $1.70B $1.60B
-应收账款 $1.77B $1.73B $1.70B $1.70B $1.60B
存货 $2.27B $2.25B $2.29B $2.29B $2.48B
其他流动资产 $646.90M $562.90M $537.20M $537.20M $460.20M
非流动资产合计 $17.70B $17.76B $17.97B $17.97B $17.65B
固定资产净值 $2.24B $2.21B $2.21B $2.21B $2.19B
-固定资产原值 $7.42B $7.30B $7.26B $7.26B $7.22B
-累计折旧 -$5.18B -$5.09B -$5.05B -$5.05B -$5.03B
商誉及其他无形资产 $14.38B $14.48B $14.66B $14.66B $14.44B
-商誉 $9.92B $9.93B $9.95B $9.95B $9.70B
-其他无形资产 $4.46B $4.55B $4.72B $4.72B $4.74B
其他非流动资产 $1.08B $1.07B $1.10B $1.10B $1.02B
负债合计 $10.17B $10.04B $10.39B $10.39B $10.72B
流动负债合计 $3.01B $2.86B $2.58B $2.58B $2.40B
应付款 $352.40M $361.20M $303.00M $303.00M $315.30M
-应付账款 $352.40M $361.20M $303.00M $303.00M $315.30M
一年内应计费用 $334.30M $293.90M $1.31B $1.31B –
短期债务及融资租赁负债 $1.20B $1.18B $587.10M $587.10M $600.00M
-一年内到期债务 $1.20B $1.18B $587.10M $587.10M $600.00M
其他流动负债 $1.13B $1.03B $382.00M $382.00M $1.49B
非流动负债合计 $7.15B $7.18B $7.80B $7.80B $8.32B
长期债务及融资租赁负债 $6.28B $6.30B $6.93B $6.93B $7.51B
-长期债务 $6.28B $6.30B $6.93B $6.93B $7.51B
一年以上递延负债 $235.60M $249.90M $244.10M $244.10M –
其他非流动负债 $638.70M $630.70M $626.10M $626.10M $806.50M
股东权益合计 $12.63B $12.68B $12.71B $12.71B $12.77B
股东权益 $12.62B $12.67B $12.70B $12.70B $12.76B
股本 $3.20M $3.20M $3.20M $3.20M $3.20M
-普通股 $3.20M $3.20M $3.20M $3.20M $3.20M
资本公积 $10.22B $10.20B $10.18B $10.18B $10.16B
留存收益 $11.96B $11.80B $11.61B $11.61B $11.52B
减:库存股 $9.39B $9.14B $8.89B $8.89B $8.64B
不影响留存收益的损益 -$163.90M -$190.40M -$205.70M -$205.70M -$283.80M
少数股东权益 $8.70M $8.20M $8.10M $8.10M $9.50M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $447.80M $359.40M $1.70B $517.40M $418.70M
持续经营经营活动现金流净额 $447.80M $359.40M $1.70B $517.40M $418.70M
持续经营净利润 $199.60M $238.30M $705.10M $137.90M $231.20M
折旧、折耗与摊销 $270.80M $270.00M $1.09B $284.00M $283.60M
其他非现金项目 -$100,000.00 $200,000.00 $100,000.00 $0.00 $0.00
营运资金变动 -$47.10M -$173.30M -$104.90M $158.60M -$121.40M
-应收款变动 -$38.50M $14.50M -$127.30M -$111.70M $3.00M
-存货变动 -$30.50M -$20.90M $98.20M $184.40M -$46.00M
-应付账款及应计费用变动 $92.00M -$183.00M $101.80M $112.90M -$51.50M
-其他营运资金变动 -$70.10M $16.10M -$177.60M -$27.00M -$26.90M
投资活动现金流净额 -$190.80M -$159.00M -$1.98B -$322.00M -$163.30M
持续经营投资活动现金流净额 -$190.80M -$159.00M -$1.98B -$322.00M -$163.30M
固定资产购置及出售净额 -$54.20M -$36.30M -$224.50M -$74.80M -$55.00M
无形资产购置及出售净额 -$62.20M -$39.00M -$52.40M -$10.00M -$10.00M
投资购置及出售净额 -$74.30M -$77.50M -$300.90M -$69.40M -$94.80M
其他投资变动净额 -$100,000.00 -$6.20M -$4.70M -$900,000.00 -$3.50M
筹资活动现金流 -$271.10M -$369.20M $326.00M -$897.00M $483.80M
持续经营筹资活动现金流净额 -$271.10M -$369.20M $326.00M -$897.00M $483.80M
债务发行及偿还净额 $30.00M $0.00 $1.03B -$600.00M $524.00M
普通股发行净额 -$250.70M -$250.10M -$487.00M -$250.00M $0.00
已付现金股利 -$46.50M -$46.90M -$190.30M -$47.50M -$47.50M
股票期权行使所得 $100,000.00 $12.30M $39.70M $1.70M $20.90M
其他筹资费用净额 -$4.00M -$84.50M -$65.50M -$1.20M -$13.60M
期末现金余额 $410.00M $424.20M $591.90M $591.90M $1.29B
现金净变动 -$14.20M -$168.80M $47.40M -$701.60M $739.20M
期初现金余额 $424.20M $591.90M $525.50M $1.29B $556.90M
汇率变动影响 $0.00 $1.10M $19.00M $800,000.00 -$3.40M
自由现金流 $331.40M $284.10M $1.42B $432.60M $353.70M
递延税款 – – -$87.20M – –
业务购买及出售净额 – – -$1.39B -$166.90M $0.00

讨论区

暂无评论——快来第一个聊聊 ZBH。

登录后参与讨论。

Scroll to Top